HelpHelp BackBack 
 
 
 
  Funding Opportunity Details
 
 -292669-RFP 58819021 Clinical Innovations for Policy/Systems Change:Innovation A - Prediabetes:Innovation B - Undiagnosed Hypertension:
  Chronic Disease Prevention
  Application Deadline: 02/19/2019 4:00 PM
 
 
Award Amount Range: Not Applicable
Project Start Date: 03/11/2019
Project End Date: 06/29/2019
Award Announcement Date: 03/11/2019
Eligible Applicant: Please see Section 1.03 of the funding opportunity
Program Officer: John McMullen
Phone: 515-281-6646 x
Email: john.mcmullen@idph.iowa.gov
Categorical Area: Health, Prevention/Treatment
 
 
Description
 
 

 It is the responsibility of the Applicant to review all attachments listed in the section below, including the Request for Proposal (RFP).

The issuance of the RFP in no way constitutes a committment by IDPH to award a contract.

Excerpts from the RFP:

 

1.01     Purpose

 

The purpose of this Request for Proposal (RFP) # 58819021 is to solicit applications that will enable the Iowa Department of Public Health (referred to as Department) to select the most qualified applicants to plan and implement sustainable policy or systems change(s) for promoting and improving screening, testing and referral for adult patients with prediabetes and improving detection of hypertension in previously undiagnosed adult patients.

 

Clinical innovations such as those supported by this RFP are one of the priorities of the

 

Centers for Disease Control and Prevention’s (CDC) program entitled “Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke” (http://www.cdc.gov.dhdsp/programs/spha). In Iowa, this CDC-funded program at the Department is called the “Health Promotion and Chronic Disease Control Partnership” (Partnership).

 

 

Innovation A - Prediabetes: Promoting and Improving Screening, Testing and Referral for Adult Patients with Prediabetes

 

To plan and implement clinical innovation interventions or policy/systems changes to assess adult patients with prediabetes or adult patients who are at high risk for developing type 2 diabetes through screening and testing and increase referrals of those adult patients to CDC-recognized lifestyle change programs.

 

 

Innovation B - Undiagnosed Hypertension: Improving Detection of Hypertension in Previously Undiagnosed Adult Patients

 

To plan and implement clinical innovation interventions or policy/systems changes that will assess undiagnosed hypertension within the applicant’s adult patient population resulting in increased number of adult patients recalled for further assessment, and diagnosis and treatment of previously undiagnosed hypertension.

 

 

1.02     Project Period and Contract Term

 

The project period shall be from March 11, 2019 to June 29, 2023.  The Department expects the initial contract period to be a three and a half month-term from March 11, 2019 to June 29, 2019. It is anticipated that all the work will be accomplished during the contract period.

 

The issuance of this RFP in no way constitutes a commitment by the Department to award a contract.

 

 

1.03     Eligibility Requirements

 

Eligible applicants must meet each of the following eligibility requirements for consideration.

 

The following entities are eligible to submit an application in accordance with this RFP:  

 

  • HRSA-designated Iowa Federally Qualified Health Centers (FQHCs)

  • Iowa health systems with one or more Health Resources and Services Administration     (HRSA)-designated Rural Health Clinics (RHCs)
  • Iowa health systems with one or more outpatient clinics
  • Accountable Care Organizations (ACOs) with one or more outpatient clinics
  • FQHC Accountable Care Organizations (ACOs)
  • Governmental entities that provide oversight to an entity providing direct patient care (i.e. Boards of Health) are eligible to submit an application in accordance with this RFP.
  •  Direct patient care is defined as providing many aspects of health care for a patient that could include screening, diagnosis, treatment, counseling and administration of medication.

 

 

Entities that were previously funded under Prediabetes Clinical Innovations - 58818002 and Clinical Innovations for Undiagnosed Hypertension - 58818003 are not be eligible for this funding, unless proposing a target area county(ies) that was not included in one of those earlier projects.

 

Electronic Communication Requirements

 

Applicant is required to maintain and provide to the Department, upon application, a current and valid email account for electronic communications with the Department.

 

Official email communication from the Department regarding this application will be issued from

 

iowa.grants@webgrantsmail.com.  Applicants are required to assure these communications are received and responded to accordingly.

 

 

1.04    Service Delivery Area

 

Innovation A -

 

The proposed service delivery area must include the applicant’s provision of screening, testing and referral. This funding opportunity is available to statewide eligible entities; however, priority will be given to health systems serving the following counties: Appanoose, Muscatine, Clinton, and Black Hawk.

 

Innovation B -

 

The proposed service delivery area must include the applicant’s provision of clinical services within at least one of the following Iowa counties: Appanoose, Black Hawk, Butler, Clinton, Fremont, Lucas, Mills, Montgomery, Muscatine, Page, Taylor and Wapello.

 

 

1.05 Available Funds

 

The source of funding is the Centers for Disease Control and Prevention (Federal). CDC-RFA-DP18-1815 PPHF18 (Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke-Financed in part by 2018 Prevention and Public Health Funds [PPHF]), Cooperative Agreement # NU58DP006514.

 

Applicants may apply for funding for Innovation A - Promoting and Improving Screening, Testing and Referral for Adult Patients with Prediabetes or Innovation B - Improving Detection of Hypertension in Previously Undiagnosed Adult Patients or both.

 

Innovation A - Promoting and Improving Screening, Testing and Referral for Adult Patients with Prediabetes

 

Applicants may apply for funding for the March 11, 2019 to June 29, 2019 period. Department anticipates up to $50,000.00 available. Actual total awards and individual contract funding levels may vary depending upon the number of qualified applicants or funding may be withdrawn completely, depending on availability of funding or any other grounds determined by the Department to be in the Department’s best interests. Actual total awards and individual contract funding will be $10,000.00 each contractor up to five (5) contractors.

 

Innovation B - Improving Detection of Hypertension in Previously Undiagnosed Adult Patients

 

Applicants may apply for funding for the March 11, 2019 to June 29, 2019 period. Department anticipates up to $110,000.00 available. Actual total awards and individual contract funding levels may vary depending upon the number of qualified applicants and the size of the clinical health system or funding may be withdrawn completely, depending on availability of funding or any other grounds determined by the Department to be in the Department’s best interest.

 

  • Up to $14,000 for small-sized clinical health systems, comprised of 1-5 clinics.

  • Up to $22,000 for medium-sized clinical health systems, comprised of 6-24 clinics.

  • Up to $34,000 for large-sized clinical health systems, comprised of 25 or more clinic sites.

  

1.06     Schedule of Important Dates  (All times and dates listed are local Iowa time.)

 

The following dates are set forth for informational purposes.  The Department reserves the right to change them.

 

EVENT

DATE

RFP Issued

January 15, 2019

Written Questions and Responses

 

Round 1 Questions Due:

Responses Posted By:

January 22, 2019

January 29, 2019

Final Questions Due:

Responses Posted By:

February 5, 2019

February 8, 2019

Applications Due

February 19, 2019 by 4:00 PM Local Iowa Time

Post Notice of Intent to Award

March 11, 2019

 

 

 

 
 
 
 Attachments
 
 Click on the File Name to open attachment
 
Description File Name File Size
A. RFP#58819021 Clinical Innovations for Policy_Systems Change_Innovation A - Prediabetes_Innovation B - Undiagnosed Hypertension A. RFP#58819021 Clinical Innovations for Policy_Systems Change_Innovation A - Prediabetes_Innovation B - Undiagnosed Hypertension_.pdf 269 KB
B. IowaGrants Registration Instructions B. IowaGrants Registration Instructions Updated 2016.pdf 873 KB
C. IDPH Application Instruction Guidance C. IDPH Application Instruction Guidance 2016.pdf 1.9 MB
D. Draft Contract Template FY19 Clinical Innovations for Policy_Systems Change_ Innovation A - Prediabetes_ Screening, Testing and Referral and Innovation B - Undiagn D. Draft Contract Template FY19 Clinical Innovations for Policy_Systems Change_ Innovation A - Prediabetes_ Screening, Testing and Referral and Innovation B - Undiagn.pdf 210 KB
E. Draft Application Score Tool Clinical Innovations for Policy_System Change_ Innovation A - Prediabetes E. Draft Application Score Tool Clinical Innovations for Policy_System Change_ Innovation A - Prediabetes_ .pdf 149 KB
F. Combined Clinical Innovations RFP-Undiagnosed Hypertension Draft Scoring Tool F. Combined Clinical Innovations RFP-Undiagnosed Hypertension Draft Scoring Tool (1).pdf 142 KB
 
 
 Website Links
 
 Click on the URL to go to website
 
URL Description
http://idph.iowa.gov/finance/funding-opportunities/general-conditions A. IDPH General Conditions
http://www.cdc.gov/dhdsp/programs/spha/index.htm B. CDC's 1815: Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke grant
http://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf C. More information about patient eligibility for DPP classes is available on page 4 of the DPRP Standards and Operating Procedures
http://www.cdc.gov/widgets/Prediabetes/html5/iframe.html D. The CDC Prediabetes Screening Test
http://doihaveprediabetes.org/pdf/Prediabetes_RiskTest_12.11.pdf. E. The ADA Prediabetes Screening Test
http://millionhearts.hhs.gov F. Undiagnosed hypertension and hypertension control resources.
www.astho.org G. Association of State and Territorial Health Officials
http://jama.jamanetwork.com/article.aspx?articleid=1935131 H. JAMA Network
www.chronicdisease.org I. National Association of Chronic Disease Directors(NACDD)
http://www.eurekalert.org/pub_releases/2014-07/nmh-rde071614.php J. EurekAlert The Global Source for Science News
http://millionhearts.hhs.gov/tools-protocols/tools.html K. CDC Hypertension Prevalence Estimator Tool
http://www.abpmcourse.com/ L. Ambulatory Blood Pressure Monitoring (ABPM) course for primary care
 
 
Questions
 
 
Submitted Date Question Answer
01/22/2019 How is policy and systems change defined in the context of this funding opportunity? Section 2.01 states: Interventions and policy(ies) or system(s) changes will result in the detection of prediabetes and undiagnosed hypertension within the adult patient populations of the applicantís clinic(s) and the subsequent prevention of diabetes and increased control of hypertension which, will lead to working with adult patients in a more equitable manner. Ideally, the policy and/or systems change will include the electronic health record identification of individuals with prediabetes or at high risk of type 2 diabetes.
01/22/2019 The RFP states that the budget form will be completed by IDPH and that dollars are awarded based on meeting the deliverables. Are there allowable and unallowable costs once funds are received? For example, can funds be used to support costs to enroll patients into a diabetes prevention program? The intent of this funding opportunity is to create a sustainable protocol/system change to identify patients with prediabetes or at high risk of type 2 diabetes and then refer them to a CDC-recognized lifestyle change program. Payments/reimbursements to the awarded contractors will be made on a deliverable basis. Once the funding is awarded for completing the deliverable, the use of the funds is decided upon by the contractor.
01/22/2019 For Innovation A, is there a deliverable specific to referrals for prediabetes patients to a diabetes prevention program? Each of the four deliverables for Innovation A is centered on the planning and implementation of a policy or systems change process that will be focused on increasing the identification of adult patients with prediabetes or high risk of type 2 diabetes and referring them to a CDC-recognized lifestyle change programs. The referral process should be a part of the intervention or policy/systems change. Please refer to Section 2.01.
01/22/2019 Will applications submitted for service areas outside of the priority counties outlined in the RFP be considered for this program? Yes, applications submitted that are for activity outside of the priority counties will be considered depending on the number and quality of applications. As this funding opportunity is a part of cooperative agreement between the Centers of Disease Control and Prevention (CDC) and the Department, the intent of this agreement is to work in high burden/priority areas in Iowa.
01/29/2019 Is there a way to see the full application before you begin documenting? You may view the RFP application guidance by clicking on the Funding Opportunity "292669 - RFP 58819021 Clinical Innovations for Policy/Systems Change:Innovation A - Prediabetes:Innovation B - Undiagnosed Hypertension" then scroll down to the "Attachments" section and click on the link for Letter A. No, you can see the components of the application listed in Section 3.02 Application Forms. From there, you will see the of components along with their descriptions. In order to see the entire application, you would need to start an application.
02/05/2019 Our health center is located in one of the preferred counties, but the closest CDC-recognized lifestyle change program is 60 miles away, which is unrealistic for most of our patients. Would the funding support local efforts to pursue program development and recognition? No, funds cannot be used to develop a CDC-recognized program. See Section 2.04 in the RFP.
 
 
 
 
 
 Iowa.gov – The Official Website of the State of Iowa. Dulles Technology Partners Inc.